Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.9M
Filings
52
Firms Hired
2
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Mikaela Naylon Give Kids a Chance Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $19,219 · Firm income: —
Matched citations: HR 1262
Mikaela Naylon Give Kids a Chance Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $19,219 · Firm income: —
Matched citations: HR 1262
PSA Screening for HIM Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $19,219 · Firm income: —
Matched citations: HR 1300
Accelerating Kids’ Access to Care Act of 2025
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $19,219 · Firm income: —
Matched citations: HR 1509
PSA Screening for HIM Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $19,219 · Firm income: —
Matched citations: S 297
Accelerating Kids’ Access to Care Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $19,219 · Firm income: —
Matched citations: S 752
Accelerating Kids’ Access to Care Act
2026 · third_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $19,219 · Firm income: —
Matched citations: S 752
Mikaela Naylon Give Kids a Chance Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $36,000 · Firm income: —
Matched citations: HR 1262
Mikaela Naylon Give Kids a Chance Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $36,000 · Firm income: —
Matched citations: HR 1262
PSA Screening for HIM Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $36,000 · Firm income: —
Matched citations: HR 1300
Accelerating Kids’ Access to Care Act of 2025
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $36,000 · Firm income: —
Matched citations: HR 1509
PSA Screening for HIM Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $36,000 · Firm income: —
Matched citations: S 297
Accelerating Kids’ Access to Care Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $36,000 · Firm income: —
Matched citations: S 752
Accelerating Kids’ Access to Care Act
2026 · second_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $36,000 · Firm income: —
Matched citations: S 752
Mikaela Naylon Give Kids a Chance Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $50,000 · Firm income: —
Matched citations: HR 1262
Mikaela Naylon Give Kids a Chance Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $50,000 · Firm income: —
Matched citations: HR 1262
PSA Screening for HIM Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $50,000 · Firm income: —
Matched citations: HR 1300
Accelerating Kids’ Access to Care Act of 2025
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $50,000 · Firm income: —
Matched citations: HR 1509
PSA Screening for HIM Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $50,000 · Firm income: —
Matched citations: S 297
Accelerating Kids’ Access to Care Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $50,000 · Firm income: —
Matched citations: S 752
Accelerating Kids’ Access to Care Act
2026 · first_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $50,000 · Firm income: —
Matched citations: S 752
Mikaela Naylon Give Kids a Chance Act
2025 · fourth_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including 1509/ S 752 the Accelerating Kids Access to Care Act and HR 1262 the Give Kids a Chance Act
Client expense: $89,000 · Firm income: —
Matched citations: HR 1262
Mikaela Naylon Give Kids a Chance Act
2025 · fourth_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $89,000 · Firm income: —
Matched citations: HR 1262
PSA Screening for HIM Act
2025 · fourth_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $89,000 · Firm income: —
Matched citations: HR 1300
Accelerating Kids’ Access to Care Act of 2025
2025 · fourth_quarter · Firm: DANA-FARBER CANCER INSTITUTE
Issues related to quality of life, survivorship and access for cancer patients including HR 1509/ S 752 the Accelerating Kids Access to Care Act, HR 1262 the Give Kids a Chance Act and HR 1300/S 297 the Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act.
Client expense: $89,000 · Firm income: —
Matched citations: HR 1509
Source: Senate LDA